Expanding Ayr acquires New Jersey medical cannabis company

MJBizCon 2023 tickets are now on sale! Discover the business solutions to elevate your cannabis retail game. Buy your ticket today.

Ayr Wellness, a multistate marijuana operator with offices in New York and Toronto, agreed to a $101 million acquisition of GSD NJ, a vertically integrated medical cannabis company.

Ayr, which changed its name in February from Ayr Strategies to Ayr Wellness, said in a statement it will pay:

  • $41 million in cash.
  • $30 million in stock.
  • $30 million in the form of promissory notes.

Earnout payments pursuant to the acquisition agreement will be capped at a maximum of $96.75 million.

Jersey City-based GSD, doing business as Garden State Dispensary, is among a dozen licensed MMJ businesses in New Jersey and one of the state’s original six operators, according to a news release.

Ayr said in a statement that it intends to retain the 110 people now employed by GSD.

The company has three operating dispensaries in New Jersey plus a 30,000-square-foot facility that houses the existing cultivation and production facilities, the release noted. GSD is building an additional 75,000-square-foot cultivation facility.

Ayr, which in December substantially increased a debt offering, either is operating or will be in Arizona, Massachusetts, New Jersey, New York, Ohio and Pennsylvania.

The MSO trades on the Canadian Securities Exchange as AYR.A.